These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. Nestle U, Kremp S, Schaefer-Schuler A, Sebastian-Welsch C, Hellwig D, Rübe C, Kirsch CM. J Nucl Med; 2005 Aug 01; 46(8):1342-8. PubMed ID: 16085592 [Abstract] [Full Text] [Related]
6. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Ashamalla H, Rafla S, Parikh K, Mokhtar B, Goswami G, Kambam S, Abdel-Dayem H, Guirguis A, Ross P, Evola A. Int J Radiat Oncol Biol Phys; 2005 Nov 15; 63(4):1016-23. PubMed ID: 15979817 [Abstract] [Full Text] [Related]
7. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. Grills IS, Yan D, Black QC, Wong CY, Martinez AA, Kestin LL. Int J Radiat Oncol Biol Phys; 2007 Mar 01; 67(3):709-19. PubMed ID: 17197120 [Abstract] [Full Text] [Related]
8. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study. Kolodziejczyk M, Kepka L, Dziuk M, Zawadzka A, Szalus N, Gizewska A, Bujko K. Int J Radiat Oncol Biol Phys; 2011 Jul 15; 80(4):1008-14. PubMed ID: 20656419 [Abstract] [Full Text] [Related]
9. Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma. Moureau-Zabotto L, Touboul E, Lerouge D, Deniaud-Alexandre E, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Kerrou K, Montravers F, Keraudy K, Tiret E, Gendre JP, Grange JD, Houry S, Talbot JN. Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):340-5. PubMed ID: 16168829 [Abstract] [Full Text] [Related]
10. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist? Hanna GG, Carson KJ, Lynch T, McAleese J, Cosgrove VP, Eakin RL, Stewart DP, Zatari A, O'Sullivan JM, Hounsell AR. Int J Radiat Oncol Biol Phys; 2010 Nov 15; 78(4):1040-51. PubMed ID: 20350798 [Abstract] [Full Text] [Related]
16. 18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: is a single standardized uptake value threshold approach appropriate? Biehl KJ, Kong FM, Dehdashti F, Jin JY, Mutic S, El Naqa I, Siegel BA, Bradley JD. J Nucl Med; 2006 Nov 15; 47(11):1808-12. PubMed ID: 17079814 [Abstract] [Full Text] [Related]
20. Microscopic disease extension in three dimensions for non-small-cell lung cancer: development of a prediction model using pathology-validated positron emission tomography and computed tomography features. van Loon J, Siedschlag C, Stroom J, Blauwgeers H, van Suylen RJ, Knegjens J, Rossi M, van Baardwijk A, Boersma L, Klomp H, Vogel W, Burgers S, Gilhuijs K. Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):448-56. PubMed ID: 20971575 [Abstract] [Full Text] [Related] Page: [Next] [New Search]